WebMar 31, 2024 · In April 2024, Matinas and BioNTech entered an exclusive research collaboration to evaluate the combination of mRNA formats and Matinas’ proprietary LNC platform technology. The Companies have initiated collaborative formulation, development, and optimization work toward planned preclinical efficacy testing. WebApr 20, 2024 · Matinas is a clinical-stage biopharmaceutical company that has developed a proprietary lipid nanocrystal (LNC) platform technology that enables the intracellular …
Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech
WebApr 11, 2024 · BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, … WebApr 11, 2024 · Matinas BioPharma Holdings, Inc. Exclusive collaboration combines BioNTech’s mRNA vaccine development expertise and Matinas’ Lipid Nanocrystal … green orange brown blue phone wires
BioNTech and Matinas BioPharma Announce Exclusive Research
WebApr 11, 2024 · The collaboration with BioNTech is an important validation from a leading global biotech company with demonstrated expertise in the design, formulation and delivery of mRNA, Matinas Co-Founder and ... WebApr 11, 2024 · BioNTech SE and Matinas BioPharma have entered into an exclusive research collaboration to evaluate the combination of mRNA formats and Matinas’ proprietary LNC platform technology. The parties will closely collaborate on formulation, optimization, and in vitro testing. WebApr 11, 2024 · (2024-04-11 NDAQ:BNTX) BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines. Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience … green orange and white shirt